Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.
Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP.
Shi W, et al.
J Neurooncol. 2014 Jun;118(2):313-319. doi: 10.1007/s11060-014-1433-2. Epub 2014 Apr 13.
J Neurooncol. 2014.
PMID: 24728831
Clinical Trial.